Further, tumors from doxorubicin-treated mice with and without FO/Se exhibited significantly lower expression of EGFR and phosphorylated (p)-EGFR proteins than did controls, with mice receiving high-dose FO/Se exhibiting the lowest tumor expression of these proteins (Figure 2D). The gene discussed is EGFR; the disease is neoplasm.